Observational Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1808-1822
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1808
Table 2 Univariate and multivariate analyses of clinicopathological factors affecting survival of patients with gastric cancer at T4 stage
Variables analysis
Univariate HR (95%CI)
P value
Multivariate HR (95%CI)
P value
IL-32 (low/high)4.338 (1.450-12.980)0.0093.287 (1.024-10.555)0.046
Tumour differentiation (low/moderate)0.710 (0.225-2.237)0.559
TNM0.0080.037
IV (reference)11
II0.034 (0.003-0.423)0.0080.069 (0.005-0.946)0.045
III0.203 (0.018-0.464)0.0040.127 (0.025-0.646)0.013
Lymph node metastasis (no/yes)0.441 (0.098-1.982)0.285
Diameter (< 5/≥ 5, cm)0.475 (0.161-1.404)0.178
Female/male0.912 (0.323-2.573)0.862
Age (≤ 60/> 60)1.950 (0.688-5.529)0.209